Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2020-08-05 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss and related disclosures. The content is a notification about a specific event concerning share certificates, not a financial report, audit, or management discussion. It is not a report or announcement of financial results, nor is it related to board changes, dividends, or mergers. This type of document fits best under Regulatory Filings (RNS), as it is a compliance-related disclosure to the stock exchanges that does not fit other specific categories.
2020-08-05 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates, referencing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements). It contains details about the lost share certificates and requests the information to be taken on record. The document is short (1394 characters) and does not contain financial data, management discussion, or report content. It is an official regulatory announcement related to share certificates but does not fit into categories like share issue, director dealings, or voting results. Therefore, it best fits the Regulatory Filings (RNS) category as a general regulatory announcement that does not neatly fit into other specific categories.
2020-08-05 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal announcement dated 28th July 2020 from the company Sanofi India Limited addressed to stock exchanges. It announces the appointment of two new directors to the Board of Directors, including their profiles and terms of appointment. There is no financial data, no report or presentation, and no mention of voting results or other regulatory filings. The content clearly fits the category of Board/Management Information, as it relates to changes in the company's board of directors.
2020-07-28 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal announcement dated 28th July 2020 addressed to stock exchanges regarding the appointment of two new directors to the company's board. It includes details about their profiles and terms of appointment. There is no financial data, earnings information, or report attached. The content clearly relates to changes in the company's board of directors. The document length is 3529 characters, which is relatively short and consistent with a management or board announcement rather than a full report. Therefore, the appropriate classification is 'Board/Management Information' (MANG).
2020-07-28 English
The Board of Directors of the Company at its Meeting held today, based on recommendation of the Nomination and Remuneration Committee approved the appointment of the following Directors: ....
Board/Management Information Classification · 95% confidence The document is a formal announcement dated 28th July 2020 addressed to stock exchanges regarding the appointment of two new directors to the company's board. It includes details about their roles, terms, and brief professional profiles. There is no financial data, earnings information, or report content. The document is clearly about changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 3529 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2020-07-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing the impact of the COVID-19 pandemic on the company's business and operations. It references SEBI regulations and provides a detailed summary of operational and financial impacts for the quarter ended 30th June 2020. The document is relatively short (3665 characters) and serves as a regulatory disclosure rather than a full financial report or earnings release. It does not contain comprehensive financial statements or detailed management analysis. The nature of the document aligns with a Regulatory Filing (RNS) as it is a compliance disclosure under SEBI regulations about material business impact, not a full report or announcement of voting results, management changes, or capital updates.
2020-07-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.